Sponsor: NRG
Sponsor Study ID: NRG-CC012CD
Study Title: NRG-CC012CD: Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment (Symon)
CTO #: 104121
NCT Number: NCT06279013
Phase: N/A
Protocol Type: Supportive Care
Age Group: Adults
Disease Sites:
Study Objectives: Test the effectiveness of automated telephone system management (ATSM) + telephone interpersonal counseling (TIPC) versus active control on patient level outcome of the summary toxicity index of 24 PRO-CTCAE symptoms that include depressive, anxiety, and other symptoms commonly experienced during oral anti-cancer treatment over weeks 1-12 (immediate effect) and 13-17 (sustained effect).